Form 4: NEOGEN Director Converts RSUs to Common Stock

NEOGEN Corp. Director James C. Borel acquired 1,777 shares of common stock through the vesting and settlement of Restricted Stock Units.

Summary

• Director James C. Borel acquired 1,777 shares of NEOGEN Corp. common stock.
• The acquisition occurred on October 27, 2025, through the vesting and settlement of Restricted Stock Units (RSUs).
• Each RSU was converted into one share of common stock at an exercise price of $6.19.
• Following this transaction, Mr. Borel directly beneficially owns 96,347 shares of common stock.

Sentiment

Score: 6

Explanation: The filing reports a routine insider transaction (RSU vesting and conversion), which is generally neutral but slightly positive as it increases director ownership, aligning interests with shareholders.

Positives

• Director James C. Borel increased his direct beneficial ownership of NEOGEN common stock by 1,777 shares, indicating continued alignment with shareholder interests.

Future Outlook

No forward-looking statements or guidance are provided in this routine insider transaction report.

Industry Context

This is a routine insider transaction, common across all industries for executive and director compensation. It does not provide specific industry-related insights or trends.

Comparison to Industry Standards

• The vesting and conversion of Restricted Stock Units (RSUs) is a standard component of executive and director compensation packages in publicly traded companies across various sectors, aligning with common industry practices for incentivizing and retaining key personnel.

Stakeholder Impact

• Shareholders: Increased direct ownership by a director may be viewed positively as it aligns management interests with shareholder interests.

Key Dates

Recommendation

This Form 4 filing details a routine vesting and conversion of Restricted Stock Units for a director, which is an expected part of executive compensation. It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. The increase in director ownership is a minor positive for alignment but not a catalyst for a 'buy' recommendation.

Keywords

NEOGEN, NEOG, Form 4, Insider Transaction, Restricted Stock Units, RSU, Common Stock, Director Ownership, Beneficial Ownership